Publicaciones en colaboración con investigadores/as de Instituto Cajal (8)

2023

  1. The sigma-1 receptor curtails endogenous opioid analgesia during sensitization of TRPV1 nociceptors

    British Journal of Pharmacology, Vol. 180, Núm. 8, pp. 1148-1167

2022

  1. Efficacy of Vafidemstat in Experimental Autoimmune Encepha-Lomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis

    Pharmaceutics, Vol. 14, Núm. 7

2021

  1. Calmodulin supports trpa1 channel association with opioid receptors and glutamate nmda receptors in the nervous tissue

    International Journal of Molecular Sciences, Vol. 22, Núm. 1, pp. 1-21

2017

  1. Gene therapy with mesenchymal stem cells expressing IFN-ß ameliorates neuroinflammation in experimental models of multiple sclerosis

    British Journal of Pharmacology, Vol. 174, Núm. 3, pp. 238-253

  2. Outcome reporting across randomised controlled trials evaluating therapeutic interventions for pre-eclampsia

    BJOG: An International Journal of Obstetrics and Gynaecology, Vol. 124, Núm. 12, pp. 1829-1839

2016

  1. Variation in outcome reporting in endometriosis trials: A systematic review

    American Journal of Obstetrics and Gynecology, Vol. 214, Núm. 4, pp. 452-464

1998

  1. Quantitative and ultrastructural changes in gila and pericytes in the parietal cortex of the aging rat

    Microscopy Research and Technique, Vol. 43, Núm. 1, pp. 34-42

1986

  1. Corticosteroidogenesis modulation by β-endorphin and dynorphin1-17 in isolated rat adrenocortical cells

    Peptides, Vol. 7, Núm. 2, pp. 237-240